Media Summary: While aging itself is not a treatable disorder, companies are focusing on longevity, cellular level treatments, and how to battle ... A drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead ... Cybin is a leading biotech company in the psychedelic therapeutic sector. Our team is focused on the development of mental ...

Lobe Sciences Investor Presentation Benzinga Global Small Cap Conference - Detailed Analysis & Overview

While aging itself is not a treatable disorder, companies are focusing on longevity, cellular level treatments, and how to battle ... A drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead ... Cybin is a leading biotech company in the psychedelic therapeutic sector. Our team is focused on the development of mental ... Scott Powell, Executive VP, CEO & Head of

Photo Gallery

Lobe Sciences | Investor Presentation | Benzinga Global Small Cap Conference
Lobe Sciences | Benzinga Healthcare Small Cap Conference
Healthcare Stocks You Should Know! | Benzinga Healthcare Small Cap Conference - Day 1 - 🟢
Benzinga Biotech Small Cap Conference | Cancer Therapies and Treatment | March 24
ChromaDex | Investor Presentation | Benzinga Global Small Cap Conference
Investing in Longevity Science | Panel | Benzinga Global Small Cap Conference
Lixte Biotechnology | Investor Presentation | Benzinga Global Small Cap Conference
Benzinga Small Cap Conference Day 2  - Growth Stocks For Your Portfolio
Cybin | Investor Presentation | Benzinga Global Small Cap Conference
Benzinga Biotech Small Cap Conference | Immunology and Unmet Medical Needs | March 25
BZreplay: Benzinga Biotech Small Cap Conference | Innovative & Emerging Therapies
VolitionRx | Benzinga Healthcare Small Cap Conference
Sponsored
View Detailed Profile
Lobe Sciences | Investor Presentation | Benzinga Global Small Cap Conference

Lobe Sciences | Investor Presentation | Benzinga Global Small Cap Conference

Lobe Sciences

Lobe Sciences | Benzinga Healthcare Small Cap Conference

Lobe Sciences | Benzinga Healthcare Small Cap Conference

Philip Young - CEO & Director,

Healthcare Stocks You Should Know! | Benzinga Healthcare Small Cap Conference - Day 1 - 🟢

Healthcare Stocks You Should Know! | Benzinga Healthcare Small Cap Conference - Day 1 - 🟢

Welcome to Day 1 Track 2 of the

Benzinga Biotech Small Cap Conference | Cancer Therapies and Treatment | March 24

Benzinga Biotech Small Cap Conference | Cancer Therapies and Treatment | March 24

Welcome to the March 24-25, 2021

ChromaDex | Investor Presentation | Benzinga Global Small Cap Conference

ChromaDex | Investor Presentation | Benzinga Global Small Cap Conference

ChromaDex Corp. is a

Sponsored
Investing in Longevity Science | Panel | Benzinga Global Small Cap Conference

Investing in Longevity Science | Panel | Benzinga Global Small Cap Conference

While aging itself is not a treatable disorder, companies are focusing on longevity, cellular level treatments, and how to battle ...

Lixte Biotechnology | Investor Presentation | Benzinga Global Small Cap Conference

Lixte Biotechnology | Investor Presentation | Benzinga Global Small Cap Conference

A drug discovery company that has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, our lead ...

Benzinga Small Cap Conference Day 2  - Growth Stocks For Your Portfolio

Benzinga Small Cap Conference Day 2 - Growth Stocks For Your Portfolio

The

Cybin | Investor Presentation | Benzinga Global Small Cap Conference

Cybin | Investor Presentation | Benzinga Global Small Cap Conference

Cybin is a leading biotech company in the psychedelic therapeutic sector. Our team is focused on the development of mental ...

Benzinga Biotech Small Cap Conference | Immunology and Unmet Medical Needs | March 25

Benzinga Biotech Small Cap Conference | Immunology and Unmet Medical Needs | March 25

Welcome to the March 24-25, 2021

BZreplay: Benzinga Biotech Small Cap Conference | Innovative & Emerging Therapies

BZreplay: Benzinga Biotech Small Cap Conference | Innovative & Emerging Therapies

The

VolitionRx | Benzinga Healthcare Small Cap Conference

VolitionRx | Benzinga Healthcare Small Cap Conference

Scott Powell, Executive VP, CEO & Head of

BZreplay: Benzinga Biotech Small Cap Conference | COVID Diagnostics and Therapeutics

BZreplay: Benzinga Biotech Small Cap Conference | COVID Diagnostics and Therapeutics

Get 47% off